Refractory atypical IgA pemphigus successfully treated with apremilast

The Journal of DermatologyEarly View LETTER TO THE EDITOR Refractory atypical IgA pemphigus successfully treated with apremilast Yuxi Zhou, Yuxi Zhou orcid.org/0000-0002-9231-2794 Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaSearch for more papers by this authorYue Xiao, Yue Xiao orcid.org/0000-0003-3013-9655 Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaSearch for more papers by this authorYiyi Wang, Yiyi Wang Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaSearch for more papers by this authorWei Li, Corresponding Author Wei Li [email protected] orcid.org/0000-0002-9585-2884 Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China Correspondence Wei Li, Department of Dermatology & Venerology, Rare Diseases Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, China. Email: [email protected]Search for more papers by this author Yuxi Zhou, Yuxi Zhou orcid.org/0000-0002-9231-2794 Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaSearch for more papers by this authorYue Xiao, Yue Xiao orcid.org/0000-0003-3013-9655 Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaSearch for more papers by this authorYiyi Wang, Yiyi Wang Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaSearch for more papers by this authorWei Li, Corresponding Author Wei Li [email protected] orcid.org/0000-0002-9585-2884 Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China Correspondence Wei Li, Department of Dermatology & Venerology, Rare Diseases Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, China. Email: [email protected]Search for more papers by this author First published: 21 October 2023 https://doi.org/10.1111/1346-8138.17007 Yuxi Zhou, Yue Xiao, and Yiyi Wang contributed equally to this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Porro AM, Caetano LVN, Maehara LSN, Enokihara MMS. Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014; 89: 96–106. 10.1590/abd1806-4841.20142459 PubMedWeb of Science®Google Scholar 2Nassim D, Alajmi A, Jfri A, Pehr K. Apremilast in dermatology: a review of literature. Dermatol Ther. 2020; 33:e14261. 10.1111/dth.14261 CASPubMedWeb of Science®Google Scholar 3Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol. 2023; 20: 217–251. 10.1038/s41423-023-00974-6 CASPubMedWeb of Science®Google Scholar 4Geller S, Gat A, Zeeli T, Hafner A, Eming R, Hertl M, et al. The expanding spectrum of IgA pemphigus: a case report and review of the literature. Br J Dermatol. 2014; 171: 650–656. 10.1111/bjd.12940 CASPubMedWeb of Science®Google Scholar 5Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol. 2012; 83: 1583–1590. 10.1016/j.bcp.2012.01.001 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation